PACB CIK: 1299130

Pacific Biosciences of California, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.11
FY22:
−0.26
FY23:
−0.26
FY24:
−0.21
FY25:
−0.11
Change from FY21 to FY25
billions USD
FY21:
−0.68
FY22:
0.12
FY23:
0.00
FY24:
0.12
FY25:
0.12
Change from FY21 to FY25
billions USD
FY21:
1.17
FY22:
0.01
FY23:
0.11
FY24:
−0.04
FY25:
0.00
billions USD
FY21:
0.38
FY22:
−0.14
FY23:
−0.15
FY24:
−0.13
FY25:
0.01
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.12
FY22:
−0.28
FY23:
−0.27
FY24:
−0.21
FY25:
−0.11

All amounts in billions USD Data source:SEC EDGAR